HCW Biologics is trading 10.5% up today at $3.69 as traders continue to respond to recent insider buying by CEO Hing Wong.
- The stock has rallied sharply since a July 29 filing showed Wong purchasing shares at an average price of $2.59.
- Today’s move is being reinforced by sustained momentum from the insider signal and a supportive biotech tape amid broader market strength.